CIK 0001659617
- Non-accelerated filer
- Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474671997
- Phone
- +1 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | KLEMP WALTER V CEO and President | Option exercise | +57 | 36,217 | ||
| 2026-11-04 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −14 | $8.46 | $118 | 36,203 |
| 2026-11-04 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −57 | 127,415 | ||
| 2026-10-15 | KLEMP WALTER V CEO and President | Option exercise | +207,500 | 771,840 | ||
| 2026-10-15 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −48,659 | $0.37 | $18K | 723,181 |
| 2026-10-15 | KLEMP WALTER V CEO and President | Grant or award · Options (right to buy) | +415,000 | 2,341,335 | ||
| 2026-10-15 | KLEMP WALTER V CEO and President | Grant or award · Restricted Stock Units | +415,000 | 2,756,335 | ||
| 2026-10-15 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −207,500 | 2,548,335 | ||
| 2026-08-03 | KLEMP WALTER V CEO and President | Purchase | +533,333 | 564,340 | ||
| 2026-08-03 | KLEMP WALTER V CEO and President | Grant or award · Series I Warrants | +1,599,999 | 1,926,335 | ||
| 2026-06-22 | KLEMP WALTER V CEO and President | Option exercise | +360 | 31,088 | ||
| 2026-06-22 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −88 | $3.12 | $275 | 31,007 |
| 2026-06-22 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −360 | 326,336 | ||
| 2026-06-20 | KLEMP WALTER V CEO and President | Option exercise | +150 | 30,765 | ||
| 2026-06-20 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −37 | $2.88 | $107 | 30,728 |
| 2026-06-20 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −150 | 326,696 | ||
| 2025-11-12 | KLEMP WALTER V CEO and President | Grant or award · Stock option (right to buy) | +830,000 | 3,210,731 | ||
| 2025-11-12 | KLEMP WALTER V CEO and President | Grant or award · Performance Based Restricted Stock Units | +750,000 | 3,960,731 | ||
| 2025-11-04 | KLEMP WALTER V CEO and President | Option exercise | +28,750 | 772,357 | ||
| 2025-11-04 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −7,001 | $0.50 | $3K | 765,356 |
Page 1 of 6 · 105 trades